Wegovy is a weight loss medication that has been approved for use in treating childhood obesity. However, understanding this complex issue is key before determining if Wegovy should be used. Childhood obesity is affected by genetic, physiological, socioeconomic, and environmental factors, and there are misconceptions and stigmas surrounding the disease. Treatment options aside from bariatric surgery are limited, but semaglutide, the active ingredient in Wegovy, has shown promising results in reducing body weight in both adults and children. The medication does have side effects and is expensive, but it is considered a potential tool in addressing the urgent problem of childhood obesity.
Source link